Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

NCT01203358 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

617

Enrollment

NETWORK

Sponsor class

Conditions

Infant, Newborn
Infant, Low Birth Weight
Infant, Small for Gestational Age
Infant, Premature
Bronchopulmonary Dysplasia

Interventions

DRUG: Exosurf
DRUG: Survanta

Sponsor

NICHD Neonatal Research Network